+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biosurgery Market - Global Forecast to 2030- Product Image
Biosurgery Market - Global Forecast to 2030- Product Image
New

Biosurgery Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082626
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biosurgery Market grew from USD 16.35 billion in 2024 to USD 17.70 billion in 2025. It is expected to continue growing at a CAGR of 8.20%, reaching USD 26.25 billion by 2030.

Over the past decade, the biosurgery market has emerged as a critical frontier in surgical innovation. From anti-adhesion barriers to advanced hemostatic agents, stakeholders are harnessing novel materials and techniques to improve patient outcomes. Rapid demographic shifts, including an aging global population and rising incidence of chronic wounds, have amplified demand for reliable surgical sealants and adhesives. Meanwhile, technological convergence is driving the development of biologically inspired composites and high-performance synthetic alternatives that offer superior handling and improved biocompatibility under challenging clinical conditions. This complex and dynamic environment necessitates a comprehensive understanding of market drivers, regulatory landscapes and competitive forces. Integrating digital health platforms, such as AI-enabled intraoperative guidance, is further enhancing the precision and efficiency of biosurgical procedures. This executive summary provides decision-makers with a clear, data-driven foundation for navigating the evolving biosurgery ecosystem. It lays the groundwork for strategic choices that align innovation pipelines with shifting healthcare priorities, ensuring that investments foster both clinical impact and commercial success. Building on this introduction, the next section examines the transformative shifts reshaping the industry’s future trajectory.

Transformative Shifts Redefining the Biosurgery Landscape

Several transformative shifts are redefining the biosurgery landscape, generating new opportunities and challenges for market participants. First, regulatory frameworks are evolving to accommodate accelerated pathways for combination products and regenerative therapies, encouraging manufacturers to pursue hybrid biologic-synthetic solutions. Concurrently, precision medicine and patient-centric approaches are influencing product development, with customized hemostatic agents and sealants tailored to individual risk profiles. Technological integration is another key trend: robotics, augmented reality and AI-enabled analytics are converging with biosurgical tools to improve intraoperative decision-making and minimize procedure times. Sustainability is also gaining prominence, prompting innovators to adopt eco-friendly materials and streamlined manufacturing processes. In parallel, the shift toward minimally invasive procedures is boosting demand for low-profile adhesives and injectable hemostats. These trends are driving R&D alliances between pharmaceuticals, device makers and biotech firms, fostering cross-disciplinary innovation. As a result, traditional product categories are blurring, giving rise to multifunctional platforms that combine anti-adhesion properties with advanced drug delivery. Transitioning from these dynamics, the subsequent section evaluates the cumulative impact of forthcoming U.S. tariffs.

Cumulative Impact of 2025 U.S. Tariffs on Biosurgery

The implementation of U.S. tariffs in 2025 on select imported surgical materials and raw reagents introduces a layer of complexity for biosurgery supply chains and cost structures. Tariffs on key inputs-ranging from biologic membranes to specialized polymers-have elevated input costs for manufacturers, compelling many to reassess sourcing strategies. Some companies have accelerated local production capabilities or pursued near-shoring partnerships with North American contract manufacturers to mitigate exposure. Others have renegotiated supplier agreements to lock in preferential pricing or secured longer-term contracts to hedge against future duty escalations. Meanwhile, downstream pricing pressures have emerged, as providers face tighter reimbursement frameworks and escalating operational expenses. Despite these headwinds, the tariff environment has stimulated investment in process optimization and lean manufacturing, enabling certain players to offset cost increases through yield improvements and waste reduction. In addition, strategic alliances with domestic raw-material producers are gaining traction, fostering integrated supply networks that enhance resilience. As the market adapts to this new cost paradigm, companies that balance tariff management with innovation momentum will be best positioned to sustain growth.

In-Depth Segmentation Insights Driving Market Dynamics

A granular segmentation analysis reveals diverse growth trajectories across product types, sources, applications, end users, technologies, materials and therapeutic areas. In product type, anti-adhesion products are gaining traction in surgeries with high risk of postoperative adhesions, whereas the hemostatic agent segment continues to expand in trauma and emergency settings. Surgical sealants and adhesives, subdivided into biological adhesives, composite adhesives and synthetic adhesives, are capturing share thanks to tailored formulations that address specific tissue types. Examining source, animal-derived materials maintain strong clinical acceptance, human blood and plasma components benefit from proven efficacy profiles, and synthetic variants appeal to cost-sensitive use cases. Application segmentation highlights cardiovascular, neurological and orthopedic surgeries as high-growth arenas, while general surgery-encompassing both abdominal and plastic procedures-remains a core volume driver. Among end users, hospitals-both private and public-account for the lion’s share of consumption, supported by infrastructure investment and high procedure volumes; ambulatory surgical centers and clinics are increasingly adopting point-of-care hemostats and sealants due to shorter recovery times. From a technology standpoint, hybrid platforms and therapeutic solutions such as autologous cell-based products and stem cell technologies are advancing personalized repair strategies. Material insight underscores a shift toward natural and biological matrices like collagen and fibrin, even as synthetic polymers such as polyglycolic acid and polylactic acid deliver controlled degradation profiles. Finally, therapeutic areas from wound management to neurology benefit from targeted biosurgical interventions that accelerate healing and reduce complications.

Key Regional Insights Shaping Global Growth

Regional analysis uncovers distinct market characteristics and diffusion patterns across the Americas, Europe, Middle East & Africa (EMEA) and Asia-Pacific. In the Americas, robust reimbursement frameworks, high R&D spending and a culture of early technology adoption propel demand for premium biosurgical solutions, particularly in cardiovascular and orthopedic procedures. EMEA exhibits a heterogeneous landscape: Western European countries emphasize stringent regulatory compliance and cost-effectiveness, while emerging markets in the Middle East and Africa are investing in capacity building and training to expand access to advanced biosurgery. Asia-Pacific markets, led by China, Japan and Australia, demonstrate rapid infrastructure expansion and growing local manufacturing capabilities. Rising healthcare expenditures, a focus on medical tourism and government initiatives to localize production are driving growth in minimally invasive and cell-based technologies. Cross-regional partnerships are on the rise, with multinational players collaborating with regional innovators to tailor product portfolios and navigate diverse regulatory regimes. These dynamics underscore the need for adaptive market entry strategies that reflect local clinical preferences and policy environments.

Strategic Company Insights and Competitive Landscape

Competitive dynamics in biosurgery are defined by a blend of legacy players and agile innovators. Aroa Biosurgery Limited and Kuros Bioscience AG are advancing regenerative matrices, while Artivion, Inc. and Baxter International Inc. focus on expanding portfolios in sealants and hemostats. B. Braun Melsungen AG and Becton, Dickinson and Company leverage global distribution networks to scale proven biologic solutions. Boston Scientific Corporation and Medtronic PLC integrate biosurgical offerings with minimally invasive platforms, targeting catheter-based interventions. Johnson & Johnson Services Inc. and Pfizer Inc. are investing in combination therapies that merge drug delivery with adhesive technologies. CSL Limited and Sanofi SA capitalize on plasma-derived proteins, whereas Stryker Corporation and Smith & Nephew plc strengthen their positions in orthopedic repair and wound management. Mid-sized specialists such as Hemostasis, LLC and Ocular Therapeutix, Inc. concentrate on niche applications from ocular surgery to trauma management. RTI Surgical, Inc. and Zimmer Biomet Holdings, Inc. pursue strategic acquisitions to diversify into biologic scaffolds, while Tissue Regenix Ltd and Cabaletta Bio, Inc. explore cell-based regenerative solutions. Collectively, these companies are forging cross-sector alliances, accelerating product development cycles and optimizing go-to-market models to capture evolving clinical needs.

Actionable Recommendations for Industry Leaders

Industry leaders must adopt proactive strategies to capitalize on emerging trends and mitigate risks. First, investment in hybrid technologies that combine synthetic scaffolds with cellular components will differentiate portfolios and meet rising demand for personalized therapies. Second, diversifying supply chains to include regional manufacturing hubs will reduce tariff exposure and enhance responsiveness to local market fluctuations. Strengthening regulatory intelligence functions will accelerate time-to-market and ensure compliance across multiple jurisdictions. Engagement with key opinion leaders and targeted clinical trials can validate novel applications and support premium pricing. Moreover, forging strategic alliances with technology partners in AI, robotics and digital health will create integrated solutions that elevate procedural efficiency. Companies should also explore value-based contracting models that align pricing with demonstrated clinical improvements, unlocking new reimbursement pathways. In parallel, expanding presence in high-growth Asia-Pacific and emerging EMEA markets through distribution partnerships or joint ventures will capture untapped volume potential. By implementing these recommendations, firms will strengthen competitive positioning and drive sustainable revenue growth.

Conclusion and Strategic Imperatives

In summary, the biosurgery market stands at the intersection of material science breakthroughs, regenerative medicine and advanced procedural technologies. The evolving regulatory landscape, coupled with demographic and clinical imperatives, is driving demand for multifunctional sealants, hemostats and adhesives that deliver predictable outcomes. While the introduction of U.S. tariffs has presented cost challenges, it has also catalyzed supply chain optimization and local capacity building. Segmentation, regional and competitive analyses underscore the diversity of growth opportunities, from high-margin cardiovascular applications in developed markets to volume-driven general surgeries in emerging regions. To navigate this complexity, companies must balance innovation investments with strategic risk management, leveraging partnerships, data analytics and robust regulatory strategies. Embracing hybrid platforms and cell-based therapies will unlock new therapeutic frontiers, while targeted market entry plans will capture localized demand. These strategic imperatives form the blueprint for sustained growth and technological leadership in the global biosurgery ecosystem.

Market Segmentation & Coverage

This research report categorizes the Biosurgery Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Anti-Adhesion Products
  • Hemostatic Agents
  • Surgical Sealants and Adhesives
    • Biological Adhesives
    • Composite Adhesives
    • Synthetic Adhesives
  • Animal
  • Human Blood/Plasma
  • Synthetic
  • Cardiovascular Surgery
  • General Surgery
    • Abdominal Surgery
    • Plastic Surgery
  • Gynecological Surgery
  • Neurological Surgery
  • Orthopedic Surgery
  • Ambulatory Surgical Centers
  • Clinics
  • Hospitals
    • Private Hospitals
    • Public Hospitals
  • Hybrid Technology
  • Therapeutic Technology
    • Autologous Cell-Based Products
    • Stem Cell Technology
  • Hybrid Materials
  • Natural/Biological Materials
    • Collagen
    • Fibrin
  • Synthetic Materials
    • Polyglycolic Acid (PGA)
    • Polylactic Acid (PLA)
  • Neurology
  • Orthopedics
  • Surgical Repair
  • Wound Management

This research report categorizes the Biosurgery Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Biosurgery Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Aroa Biosurgery Limited
  • Artivion, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson, and Company
  • Boston Scientific Corporation
  • Cabaletta Bio, Inc.
  • CSL Limited
  • Getinge AB
  • Hemostasis, LLC
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services Inc.
  • Kuros Bioscience AG
  • Medtronic PLC
  • Ocular Therapeutix, Inc.
  • Orthofix Medical, Inc.
  • Pfizer Inc.
  • RTI Surgical, Inc.
  • Samyang Holdings Corporation
  • Sanofi SA
  • Smith & Nephew plc
  • Stryker Corporation
  • Tissue Regenix Ltd
  • Zimmer Biomet Holdings, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biosurgery Market, by Product Type
8.1. Introduction
8.2. Anti-Adhesion Products
8.3. Hemostatic Agents
8.4. Surgical Sealants and Adhesives
8.4.1. Biological Adhesives
8.4.2. Composite Adhesives
8.4.3. Synthetic Adhesives
9. Biosurgery Market, by Source
9.1. Introduction
9.2. Animal
9.3. Human Blood/Plasma
9.4. Synthetic
10. Biosurgery Market, by Application
10.1. Introduction
10.2. Cardiovascular Surgery
10.3. General Surgery
10.3.1. Abdominal Surgery
10.3.2. Plastic Surgery
10.4. Gynecological Surgery
10.5. Neurological Surgery
10.6. Orthopedic Surgery
11. Biosurgery Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Clinics
11.4. Hospitals
11.4.1. Private Hospitals
11.4.2. Public Hospitals
12. Biosurgery Market, by Technology
12.1. Introduction
12.2. Hybrid Technology
12.3. Therapeutic Technology
12.3.1. Autologous Cell-Based Products
12.3.2. Stem Cell Technology
13. Biosurgery Market, by Material
13.1. Introduction
13.2. Hybrid Materials
13.3. Natural/Biological Materials
13.3.1. Collagen
13.3.2. Fibrin
13.4. Synthetic Materials
13.4.1. Polyglycolic Acid (PGA)
13.4.2. Polylactic Acid (PLA)
14. Biosurgery Market, by Therapeutic Area
14.1. Introduction
14.2. Neurology
14.3. Orthopedics
14.4. Surgical Repair
14.5. Wound Management
15. Americas Biosurgery Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Biosurgery Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Biosurgery Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Aroa Biosurgery Limited
18.3.2. Artivion, Inc.
18.3.3. B. Braun Melsungen AG
18.3.4. Baxter International Inc.
18.3.5. Becton, Dickinson, and Company
18.3.6. Boston Scientific Corporation
18.3.7. Cabaletta Bio, Inc.
18.3.8. CSL Limited
18.3.9. Getinge AB
18.3.10. Hemostasis, LLC
18.3.11. Integra LifeSciences Corporation
18.3.12. Johnson & Johnson Services Inc.
18.3.13. Kuros Bioscience AG
18.3.14. Medtronic PLC
18.3.15. Ocular Therapeutix, Inc.
18.3.16. Orthofix Medical, Inc.
18.3.17. Pfizer Inc.
18.3.18. RTI Surgical, Inc.
18.3.19. Samyang Holdings Corporation
18.3.20. Sanofi SA
18.3.21. Smith & Nephew plc
18.3.22. Stryker Corporation
18.3.23. Tissue Regenix Ltd
18.3.24. Zimmer Biomet Holdings, Inc.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. BIOSURGERY MARKET MULTI-CURRENCY
FIGURE 2. BIOSURGERY MARKET MULTI-LANGUAGE
FIGURE 3. BIOSURGERY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOSURGERY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOSURGERY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOSURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOSURGERY MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOSURGERY MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOSURGERY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOSURGERY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOSURGERY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOSURGERY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOSURGERY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOSURGERY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIOSURGERY MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIOSURGERY MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL BIOSURGERY MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 20. GLOBAL BIOSURGERY MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS BIOSURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS BIOSURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES BIOSURGERY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES BIOSURGERY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. BIOSURGERY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. BIOSURGERY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOSURGERY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOSURGERY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOSURGERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOSURGERY MARKET SIZE, BY ANTI-ADHESION PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOSURGERY MARKET SIZE, BY HEMOSTATIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOSURGERY MARKET SIZE, BY SURGICAL SEALANTS AND ADHESIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOSURGERY MARKET SIZE, BY BIOLOGICAL ADHESIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOSURGERY MARKET SIZE, BY COMPOSITE ADHESIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOSURGERY MARKET SIZE, BY SYNTHETIC ADHESIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOSURGERY MARKET SIZE, BY SURGICAL SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOSURGERY MARKET SIZE, BY ANIMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOSURGERY MARKET SIZE, BY HUMAN BLOOD/PLASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOSURGERY MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOSURGERY MARKET SIZE, BY ABDOMINAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOSURGERY MARKET SIZE, BY PLASTIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOSURGERY MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOSURGERY MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOSURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOSURGERY MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOSURGERY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOSURGERY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOSURGERY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOSURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOSURGERY MARKET SIZE, BY HYBRID TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOSURGERY MARKET SIZE, BY THERAPEUTIC TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOSURGERY MARKET SIZE, BY AUTOLOGOUS CELL-BASED PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOSURGERY MARKET SIZE, BY STEM CELL TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOSURGERY MARKET SIZE, BY THERAPEUTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOSURGERY MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOSURGERY MARKET SIZE, BY HYBRID MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOSURGERY MARKET SIZE, BY NATURAL/BIOLOGICAL MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOSURGERY MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOSURGERY MARKET SIZE, BY FIBRIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOSURGERY MARKET SIZE, BY NATURAL/BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOSURGERY MARKET SIZE, BY SYNTHETIC MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOSURGERY MARKET SIZE, BY POLYGLYCOLIC ACID (PGA), BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOSURGERY MARKET SIZE, BY POLYLACTIC ACID (PLA), BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIOSURGERY MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIOSURGERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BIOSURGERY MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BIOSURGERY MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BIOSURGERY MARKET SIZE, BY SURGICAL REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BIOSURGERY MARKET SIZE, BY WOUND MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS BIOSURGERY MARKET SIZE, BY SURGICAL SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BIOSURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS BIOSURGERY MARKET SIZE, BY THERAPEUTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS BIOSURGERY MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BIOSURGERY MARKET SIZE, BY NATURAL/BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS BIOSURGERY MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS BIOSURGERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA BIOSURGERY MARKET SIZE, BY SURGICAL SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA BIOSURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA BIOSURGERY MARKET SIZE, BY THERAPEUTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA BIOSURGERY MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA BIOSURGERY MARKET SIZE, BY NATURAL/BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA BIOSURGERY MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA BIOSURGERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL BIOSURGERY MARKET SIZE, BY SURGICAL SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL BIOSURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL BIOSURGERY MARKET SIZE, BY THERAPEUTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL BIOSURGERY MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL BIOSURGERY MARKET SIZE, BY NATURAL/BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL BIOSURGERY MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL BIOSURGERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 95. CANADA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. CANADA BIOSURGERY MARKET SIZE, BY SURGICAL SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 97. CANADA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 98. CANADA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. CANADA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 100. CANADA BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. CANADA BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 102. CANADA BIOSURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. CANADA BIOSURGERY MARKET SIZE, BY THERAPEUTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 104. CANADA BIOSURGERY MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 105. CANADA BIOSURGERY MARKET SIZE, BY NATURAL/BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 106. CANADA BIOSURGERY MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 107. CANADA BIOSURGERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 108. MEXICO BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. MEXICO BIOSURGERY MARKET SIZE, BY SURGICAL SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 110. MEXICO BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 111. MEXICO BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. MEXICO BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 113. MEXICO BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. MEXICO BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 115. MEXICO BIOSURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. MEXICO BIOSURGERY MARKET SIZE, BY THERAPEUTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. MEXICO BIOSURGERY MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 118. MEXICO BIOSURGERY MARKET SIZE, BY NATURAL/BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 119. MEXICO BIOSURGERY MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 120. MEXICO BIOSURGERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES BIOSURGERY MARKET SIZE, BY SURGICAL SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES BIOSURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES BIOSURGERY MARKET SIZE, BY THERAPEUTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES BIOSURGERY MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES BIOSURGERY MARKET SIZE, BY NATURAL/BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES BIOSURGERY MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 133. UNITED STATES BIOSURGERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 134. UNITED STATES BIOSURGERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY SURGICAL SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 138. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY THERAPEUTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 144. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY NATURAL/BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 146. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 147. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 148. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 149. AUSTRALIA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 150. AUSTRALIA BIOSURGERY MARKET SIZE, BY SURGICAL SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 151. AUSTRALIA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 152. AUSTRALIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. AUSTRALIA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 154. AUSTRALIA BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. AUSTRALIA BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 156. AUSTRALIA BIOSURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 157. AUSTRALIA BIOSURGERY MARKET SIZE, BY THERAPEUTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 158. AUSTRALIA BIOSURGERY MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 159. AUSTRALIA BIOSURGERY MARKET SIZE, BY NATURAL/BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 160. AUSTRALIA BIOSURGERY MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 161. AUSTRALIA BIOSURGERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 162. CHINA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 163. CHINA BIOSURGERY MARKET SIZE, BY SURGICAL SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 164. CHINA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 165. CHINA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. CHINA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 167. CHINA BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. CHINA BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 169. CHINA BIOSURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 170. CHINA BIOSURGERY MARKET SIZE, BY THERAPEUTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. CHINA BIOSURGERY MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 172. CHINA BIOSURGERY MARKET SIZE, BY NATURAL/BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 173. CHINA BIOSURGERY MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 174. CHINA BIOSURGERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 175. INDIA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 176. INDIA BIOSURGERY MARKET SIZE, BY SURGICAL SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 177. INDIA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 178. INDIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. INDIA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 180. INDIA BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. INDIA BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 182. INDIA BIOSURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 183. INDIA BIOSURGERY MARKET SIZE, BY THERAPEUTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 184. INDIA BIOSURGERY MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 185. INDIA BIOSURGERY MARKET SIZE, BY NATURAL/BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 186. INDIA BIOSURGERY MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 187. INDIA BIOSURGERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 188. INDONESIA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. INDONESIA BIOSURGERY MARKET SIZE, BY SURGICAL SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 190. INDONESIA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 191. INDONESIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. INDONESIA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 193. INDONESIA BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. INDONESIA BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 195. INDONESIA BIOSURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 196. INDONESIA BIOSURGERY MARKET SIZE, BY THERAPEUTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 197. INDONESIA BIOSURGERY MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 198. INDONESIA BIOSURGERY MARKET SIZE, BY NATURAL/BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 199. INDONESIA BIOSURGERY MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 200. INDONESIA BIOSURGERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 201. JAPAN BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 202. JAPAN BIOSURGERY MARKET SIZE, BY SURGICAL SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 203. JAPAN BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 204. JAPAN BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. JAPAN BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 206. JAPAN BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. JAPAN BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 208. JAPAN BIOSURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 209. JAPAN BIOSURGERY MARKET SIZE, BY THERAPEUTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 210. JAPAN BIOSURGERY MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 211. JAPAN BIOSURGERY MARKET SIZE, BY NATURAL/BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 212. JAPAN BIOSURGERY MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 213. JAPAN BIOSURGERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 214. MALAYSIA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 215. MALAYSIA BIOSURGERY MARKET SIZE, BY SURGICAL SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 216. MALAYSIA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 217. MALAYSIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 219. MALAYSIA BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. MALAYSIA BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 221. MALAYSIA BIOSURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 222. MALAYSIA BIOSURGERY MARKET SIZE, BY THERAPEUTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 223. MALAYSIA BIOSURGERY MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 224. MALAYSIA BIOSURGERY MARKET SIZE, BY NATURAL/BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 225. MALAYSIA BIOSURGERY MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 226. MALAYSIA BIOSURGERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 227. PHILIPPINES BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 228. PHILIPPINES BIOSURGERY MARKET SIZE, BY SURGICAL SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 229. PHILIPPINES BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 230. PHILIPPINES BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. PHILIPPINES BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 232. PHILIPPINES BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. PHILIPPINES BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 234. PHILIPPINES BIOSURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 235. PHILIPPINES BIOSURGERY MARKET SIZE, BY THERAPEUTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 236. PHILIPPINES BIOSURGERY MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 237. PHILIPPINES BIOSURGERY MARKET SIZE, BY NATURAL/BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 238. PHILIPPINES BIOSURGERY MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 239. PHILIPPINES BIOSURGERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 240. SINGAPORE BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 241. SINGAPORE BIOSURGERY MARKET SIZE, BY SURGICAL SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 242. SINGAPORE BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 243. SINGAPORE BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. SINGAPORE BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 245. SINGAPORE BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. SINGAPORE BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 247. SINGAPORE BIOSURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 248. SINGAPORE BIOSURGERY MARKET SIZE, BY THERAPEUTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 249. SINGAPORE BIOSURGERY MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 250. SINGAPORE BIOSURGERY MARKET SIZE, BY NATURAL/BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 251. SINGAPORE BIOSURGERY MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 252. SINGAPORE BIOSURGERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 253. SOUTH KOREA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. SOUTH KOREA BIOSURGERY MARKET SIZE, BY SURGICAL SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 255. SOUTH KOREA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 256. SOUTH KOREA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. SOUTH KOREA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 258. SOUTH KOREA BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. SOUTH KOREA BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 260. SOUTH KOREA BIOSURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 261. SOUTH KOREA BIOSURGERY MARKET SIZE, BY THERAPEUTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 262. SOUTH KOREA BIOSURGERY MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 263. SOUTH KOREA BIOSURGERY MARKET SIZE, BY NATURAL/BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 264. SOUTH KOREA BIOSURGERY MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 265. SOUTH KOREA BIOSURGERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 266. TAIWAN BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. TAIWAN BIOSURGERY MARKET SIZE, BY SURGICAL SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 268. TAIWAN BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 269. TAIWAN BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. TAIWAN BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 271. TAIWAN BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 272. TAIWAN BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 273. TAIWAN BIOSURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 274. TAIWAN BIOSURGERY MARKET SIZE, BY THERAPEUTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 275. TAIWAN BIOSURGERY MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN BIOSURGERY MARKET SIZE, BY NATURAL/BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 277. TAIWAN BIOSURGERY MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 278. TAIWAN BIOSURGERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 279. THAILAND BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 280. THAILAND BIOSURGERY MARKET SIZE, BY SURGICAL SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 281. THAILAND BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 282. THAILAND BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. THAILAND BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 284. THAILAND BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. THAILAND BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 286. THAILAND BIOSURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 287. THAILAND BIOSURGERY MARKET SIZE, BY THERAPEUTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 288. THAILAND BIOSURGERY MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 289. THAILAND BIOSURGERY MARKET SIZE, BY NATURAL/BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 290. THAILAND BIOSURGERY MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 291. THAILAND BIOSURGERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 292. VIETNAM BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 293. VIETNAM BIOSURGERY MARKET SIZE, BY SURGICAL SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 294. VIETNAM BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 295. VIETNAM BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 296. VIETNAM BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 297. VIETNAM BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. VIETNAM BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 299. VIETNAM BIOSURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 300. VIETNAM BIOSURGERY MARKET SIZE, BY THERAPEUTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 301. VIETNAM BIOSURGERY MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 302. VIETNAM BIOSURGERY MARKET SIZE, BY NATURAL/BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 303. VIETNAM BIOSURGERY MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 304. VIETNAM BIOSURGERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY SURGICAL SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY THERAPEUTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY NATURAL/BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 319. DENMARK BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 320. DENMARK BIOSURGERY MARKET SIZE, BY SURGICAL SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 321. DENMARK BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 322. DENMARK BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 323. DENMARK BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 324. DENMARK BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 325. DENMARK BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 326. DENMARK BIOSURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 327. DENMARK BIOSURGERY MARKET SIZE, BY THERAPEUTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 328. DENMARK BIOSURGERY MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 329. DENMARK BIOSURGERY MARKET SIZE, BY NATURAL/BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 330. DENMARK BIOSURGERY MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 331. DENMARK BIOSURGERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 332. EGYPT BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 333. EGYPT BIOSURGERY MARKET SIZE, BY SURGICAL SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 334. EGYPT BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 335. EGYPT BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 336. EGYPT BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 337. EGYPT BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 338. EGYPT BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 339. EGYPT BIOSURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 340. EGYPT BIOSURGERY MARKET SIZE, BY THERAPEUTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 341. EGYPT BIOSURGERY MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 342. EGYPT BIOSURGERY MARKET SIZE, BY NATURAL/BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 343. EGYPT BIOSURGERY MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 344. EGYPT BIOSURGERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 345. FINLAND BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 346. FINLAND BIOSURGERY MARKET SIZE, BY SURGICAL SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 347. FINLAND BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 348. FINLAND BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 349. FINLAND BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 350. FINLAND BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 351. FINLAND BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 352. FINLAND BIOSURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 353. FINLAND BIOSURGERY MARKET SIZE, BY THERAPEUTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 354. FINLAND BIOSURGERY MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 355. FINLAND BIOSURGERY MARKET SIZE, BY NATURAL/BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 356. FINLAND BIOSURGERY MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 357. FINLAND BIOSURGERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 358. FRANCE BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 359. FRANCE BIOSURGERY MARKET SIZE, BY SURGICAL SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 360. FRANCE BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 361. FRANCE BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 362. FRANCE BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 363. FRANCE BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 364. FRANCE BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 365. FRANCE BIOSURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 366. FRANCE BIOSURGERY MARKET SIZE, BY THERAPEUTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 367. FRANCE BIOSURGERY MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 368. FRANCE BIOSURGERY MARKET SIZE, BY NATURAL/BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 369. FRANCE BIOSURGERY MARKET SI

Companies Mentioned

  • Aroa Biosurgery Limited
  • Artivion, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson, and Company
  • Boston Scientific Corporation
  • Cabaletta Bio, Inc.
  • CSL Limited
  • Getinge AB
  • Hemostasis, LLC
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services Inc.
  • Kuros Bioscience AG
  • Medtronic PLC
  • Ocular Therapeutix, Inc.
  • Orthofix Medical, Inc.
  • Pfizer Inc.
  • RTI Surgical, Inc.
  • Samyang Holdings Corporation
  • Sanofi SA
  • Smith & Nephew plc
  • Stryker Corporation
  • Tissue Regenix Ltd
  • Zimmer Biomet Holdings, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Biosurgery Market Size, Share and Trends Analysis Report by Product (Surgical Sealants, Hemostatic Agents, Adhesion Barriers, Soft Tissue Attachments), Application (General Surgery, Orthopedic Surgery), and Region 2024-2030 - Product Image

Biosurgery Market Size, Share and Trends Analysis Report by Product (Surgical Sealants, Hemostatic Agents, Adhesion Barriers, Soft Tissue Attachments), Application (General Surgery, Orthopedic Surgery), and Region 2024-2030

  • Report
  • 100 Pages
  • Global
From
Biosurgery Market Report by Product, Source, Application, End User, and Region 2024-2032 - Product Image

Biosurgery Market Report by Product, Source, Application, End User, and Region 2024-2032

  • Report
  • 146 Pages
  • Global
From
Biosurgery Market based by Product Type, By Application, By Source, Regional Outlook - Global Forecast up to 2030 - Product Image

Biosurgery Market based by Product Type, By Application, By Source, Regional Outlook - Global Forecast up to 2030

  • Report
  • 146 Pages
  • Global
From
Biosurgery - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Biosurgery - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From

About the Biosurgery Market

Biosurgery is a rapidly growing field of medical technology that focuses on the use of biological materials to repair, replace, or supplement damaged or missing tissue. It is used in a variety of surgical procedures, including reconstructive surgery, orthopedic surgery, and plastic surgery. Biosurgery products are designed to provide a more natural and effective solution to tissue repair and regeneration. These products are often made from biocompatible materials, such as collagen, hyaluronic acid, and other proteins, and are designed to be minimally invasive and to reduce the risk of infection. Biosurgery products are used in a variety of surgical procedures, including wound healing, tissue engineering, and regenerative medicine. They are also used to treat a variety of conditions, such as burns, ulcers, and hernias. Biosurgery products are also used in cosmetic surgery, such as breast augmentation and facial reconstruction. Some of the companies in the biosurgery market include Allergan, Baxter, Bausch Health, Covidien, Johnson & Johnson, Medtronic, and Smith & Nephew. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.